sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
6-Feb-2016 23:06
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 1151.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>

Public Release: 22-Sep-2014
Canada funds 22 innovative projects to help save 'Every Woman, Every Child'
Grand Challenges Canada announces 22 grants to innovators in Canada and the developing world to address maternal, newborn and child health. MNCH, a centerpiece of Canada's international assistance efforts, will be the focus of events and talks throughout this month's UN General Assembly in New York.
Grand Challenges Canada

Contact: Terry Collins
Terry Collins Assoc

Public Release: 19-Sep-2014
PLOS Currents: Outbreaks
Research predicts possible 6,800 new Ebola cases this month
Arizona State University and Harvard University researchers also discovered through modelling analysis that the rate of rise in cases significantly increased in August in Liberia and Guinea, around the time that a mass quarantine was put in place, indicating that the mass quarantine efforts may have made the outbreak worse than it would have been otherwise.
NIH/National Institute of General Medical Sciences

Contact: Julie Newberg
Arizona State University

Public Release: 18-Sep-2014
PLOS Pathogens
Research milestone in CCHF virus could help identify new treatments
New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factors essential for CCHFV infection. This discovery has the potential to lead to novel targets for therapeutic interventions against the pathogen.
Ewing Halsell Foundation, Douglass Foundation, US Defense Threat Reduction Agency

Contact: Lisa Cruz
Texas Biomedical Research Institute

Public Release: 18-Sep-2014
New insights on an ancient plague could improve treatments for infections
Dangerous new pathogens such as the Ebola virus invoke scary scenarios of deadly epidemics, but even ancient scourges such as the bubonic plague are still providing researchers with new insights on how the body responds to infections. In a study published online Sept. 18, 2014, in the journal Immunity, researchers at Duke Medicine and Duke-NUS Graduate Medical School Singapore detail how the bacteria that cause bubonic plague hitchhike on immune cells in the lymph nodes and ride into the lungs and the blood stream
National Institutes of Health

Contact: Sarah Avery
Duke University Medical Center

Public Release: 18-Sep-2014
Science Translational Medicine
A new way to prevent the spread of devastating diseases
Researchers around the country are adopting a technique developed in the Caltech lab of Nobel Laureate David Baltimore to try to guard against infection. The method, called VIP, was originally designed to trigger an immune response to HIV, and because of its success with HIV is now being studied, in mice, for protection against influenza, malaria, hepatitis C, and tuberculosis.

Contact: Deborah Williams-Hedges
California Institute of Technology

Public Release: 18-Sep-2014
Annals of Oncology
Experts issue plea for better research and education for advanced breast cancer
Breast cancer experts around the world have issued a plea to researchers, academics, drug companies, funders and advocates to carry out high quality research and clinical trials for advanced breast cancer, a disease which is almost always fatal and for which there are many unanswered questions. The plea is published in the latest international consensus guidelines for the management of advanced breast cancer, published simultaneously in the leading cancer journals The Breast and Annals of Oncology.

Contact: Emma Mason
European Society for Medical Oncology

Public Release: 18-Sep-2014
World population to keep growing this century, hit 11 billion by 2100
The chance that world population in 2100 will be between 9.6 billion and 12.3 billion people is 80 percent, according to the first such United Nations forecast to incorporate modern statistical tools.
National Institutes of Health

Contact: Hannah Hickey
University of Washington

Public Release: 16-Sep-2014
Ebola outbreak 'out of all proportion' and severity cannot be predicted
A mathematical model that replicates Ebola outbreaks can no longer be used to ascertain the eventual scale of the current epidemic, finds research conducted by the University of Warwick. Dr. Thomas House, of the University's Warwick Mathematics Institute, developed a model that incorporated data from past outbreaks that successfully replicated their eventual scale.
Engineering and Physical Sciences Research Council

Contact: Tom Frew
University of Warwick

Public Release: 16-Sep-2014
Proceedings of the National Academy of Sciences
Pairing social networks with social motives to close the science gap
Noshir Contractor is leading a survey of 14,000 health workers in India to discover how to best disseminate public health information.

Contact: Megan Fellman
Northwestern University

Public Release: 16-Sep-2014
PLOS Medicine
World Health Organization policy improves use of medicines
In this issue of PLOS Medicine, Kathleen Holloway from the World Health Organization and David Henry evaluated data on reported adherence to World Health Organization essential medicines practices and measures of quality use of medicines from 56 low and middle income countries for 2002-2008. They compared the countries' government-reported implementation of 36 essential medicines policies with independent survey results for 10 validated indicators of quality use of medicines.
World Health Organization, World Health Organization Collaborating Centre at Boston and Harvard Universities

Contact: Maya Sandler

Public Release: 15-Sep-2014
Acta Crystallographica Section D
Protein secrets of Ebola virus
The current Ebola virus outbreak in West Africa, which has claimed more than 2000 lives, has highlighted the need for a deeper understanding of the molecular biology of the virus that could be critical in the development of vaccines or antiviral drugs to treat or prevent Ebola hemorrhagic fever.
DOD/Defense Threat Reduction Agency

Contact: ja@iucr.org
International Union of Crystallography

Public Release: 15-Sep-2014
Japanese Global Health Fund awards $33.5 million to develop vaccines, drugs for neglected diseases
The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle three insect-borne diseases -- malaria, dengue and Chagas disease. The announcement marks the GHIT Fund's third round of grant investments since November 2013 -- totaling $33.5 million.
Global Health Innovative Technology Fund

Contact: Katy Lenard
Burness Communications

Public Release: 12-Sep-2014
Advancing the science for health programming in crisis conditions
Humanitarian crises are becoming increasingly complex and a growing threat to the health and safety of populations. An improved evidence-base to guide interventions in the countries most vulnerable to these conditions is more critical than ever. A paper by researchers at Columbia University's Mailman School of Public Health looks at the challenges of doing research in such settings and the strategies that must be adopted for scientific advance.

Contact: Stephanie Berger
Columbia University's Mailman School of Public Health

Public Release: 12-Sep-2014
How evolutionary principles could help save our world
The age of the Anthropocene -- the scientific name given to our current geologic age -- is dominated by human impacts on our environment. A warming climate. Increased resistance of pathogens and pests. A swelling population. Coping with these modern global challenges requires application of what one might call a more-ancient principle: evolution.
National Science Foundation

Contact: Jessica Arriens
National Science Foundation

Public Release: 11-Sep-2014
Ebola paper demonstrates disease transmission rate
Transmission rates for each single case of Ebola consistently showed at least one new case of the disease being transmitted. Country-specific analysis of transmission rates in Liberia and Sierra Leone showed on average between one and two new cases for every existing case.

Contact: Julie Newberg
Arizona State University

Public Release: 11-Sep-2014
Sepsis kills over 6,000,000 children in developing world: App-device could help save them
Two signs that someone might have sepsis are if they have a high pulse rate as well as arterial hypoxemia or blood oxygen deficiency. Both of these vital signs -- pulse rate and blood oxygen level -- can be quickly and easily measured with a new app-device that turns smartphones and tablets into pulse oximeters.

Contact: Pamela Clarke
LionsGate Technologies (LGTmedical)

Public Release: 11-Sep-2014
Penn Medicine bioethicists call for greater first-world response to Ebola outbreak
Amid recent discussion about the Ebola crisis in West Africa, Penn Medicine physicians say that high-income countries like the United States have an obligation to help those affected by the outbreak and to advance research to fight the deadly disease -- including in the context of randomized clinical trials of new drugs to combat the virus.

Contact: Anna Duerr
University of Pennsylvania School of Medicine

Public Release: 10-Sep-2014
Champalimaud Award recognizes revolutionary treatment of devastating blindness diseases
The 2014 Antonio Champalimaud Vision Award is given to seven researchers for the development of anti-angiogenic therapy for retinal disease. The conditions it helps treat, especially age-related macular degeneration and diabetic retinopathy, are the most important causes of blindness in several countries, and their prevalence is growing with the increasing age of the population and the global epidemic of diabetes linked to dietary habits and obesity.
Champalimaud Foundation

Contact: Vitor Cunha

Public Release: 9-Sep-2014
Nature Communications
Researchers unlock the genetic code of cancer-causing liver fluke parasite
An international team of scientists from Singapore, Thailand, China and Australia has cracked the genetic code of the liver fluke parasite, Opisthorchis viverrini, using a unique DNA analysis technique developed at A*STAR's Genome Institute of Singapore.

Contact: Winnie Lim
Biomedical Sciences Institutes (BMSI)

Public Release: 9-Sep-2014
International Journal of Innovative Computing and Applications
An evolutionary approach to epidemics
An evolutionary analysis of public health data during a major disease outbreak, such as bird flu, E. coli contamination of food or the current Ebola outbreak could help the emergency services plan their response and contain the disease more effectively. Details are reported in the International Journal of Innovative Computing and Applications.

Contact: Albert Ang
Inderscience Publishers

Public Release: 9-Sep-2014
Nature Communications
Weakness in malaria parasite fats could see new treatments
A new study has revealed a weak spot in the complex life cycle of malaria, which could be exploited to prevent the spread of the deadly disease, and may even lead to a vaccine. It found female malaria parasites put on fat differently to male ones, a process that can be used to develop drug targets.

Contact: Alex Maier
Australian National University

Public Release: 9-Sep-2014
PLOS Medicine
Prioritizing pregnant women in malaria endemic regions for bed nets from clinics
Donors, Ministries of Health, implementing agencies, and other partners should prioritize providing pregnant women in malaria endemic regions with long-lasting insecticide treated nets through antenatal care clinics to help prevent malaria and its adverse effects on mother and infant, according to experts from the UK and US, writing in this week's PLOS Medicine.
United States Agency for International Development, Johns Hopkins University Cooperative Agreement for the NetWorks Project

Contact: Maya Sandler

Public Release: 9-Sep-2014
PLOS Medicine
After 2 years on antiretroviral therapy, survival in South African patients meets rates from North America
Provided that therapy is started promptly, South Africans with HIV have chances of remaining alive beyond two years on antiretroviral therapy that are comparable to those of North American patients, according to new research in PLOS Medicine by Andrew Boulle of the University of Cape Town and colleagues.

Contact: Maya Sandler

Public Release: 8-Sep-2014
Nature Medicine
Rapid and durable protection against ebola virus with new vaccine regimens
One shot of an experimental vaccine made from two Ebola virus gene segments incorporated into a chimpanzee cold virus vector, called chimp adenovirus type 3 or ChAd3, protected all four macaque monkeys exposed to high levels of Ebola virus 5 weeks after inoculation, report National Institutes of Health scientists and their collaborators.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Sep-2014
Nature Immunology
Scientists reveal cell secret potentially useful for vaccines
Researchers open a new page in the immune system's playbook, discovering more chatter goes on among the body's infection fighters than was suspected.

Contact: Paula Brewer Byron
Virginia Tech

Showing releases 851-875 out of 1151.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>